N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma

Abstract In pancreatic cancer, methyltransferase-like 3 (METTL3), a N(6)-methyladenosine (m6A) methyltransferase, has a favorable effect on tumors and is a risk factor for patients’ prognosis. However, the details of what genes are regulated by METTL3 remain unknown. Several RNAs are methylated, and...

Full description

Bibliographic Details
Main Authors: Shotaro Tatekawa, Keisuke Tamari, Ryota Chijimatsu, Masamitsu Konno, Daisuke Motooka, Suguru Mitsufuji, Hirofumi Akita, Shogo Kobayashi, Yoshiki Murakumo, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii, Kazuhiko Ogawa
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-15196-5
_version_ 1818235536752508928
author Shotaro Tatekawa
Keisuke Tamari
Ryota Chijimatsu
Masamitsu Konno
Daisuke Motooka
Suguru Mitsufuji
Hirofumi Akita
Shogo Kobayashi
Yoshiki Murakumo
Yuichiro Doki
Hidetoshi Eguchi
Hideshi Ishii
Kazuhiko Ogawa
author_facet Shotaro Tatekawa
Keisuke Tamari
Ryota Chijimatsu
Masamitsu Konno
Daisuke Motooka
Suguru Mitsufuji
Hirofumi Akita
Shogo Kobayashi
Yoshiki Murakumo
Yuichiro Doki
Hidetoshi Eguchi
Hideshi Ishii
Kazuhiko Ogawa
author_sort Shotaro Tatekawa
collection DOAJ
description Abstract In pancreatic cancer, methyltransferase-like 3 (METTL3), a N(6)-methyladenosine (m6A) methyltransferase, has a favorable effect on tumors and is a risk factor for patients’ prognosis. However, the details of what genes are regulated by METTL3 remain unknown. Several RNAs are methylated, and what genes are favored in pancreatic cancer remains unclear. By epitranscriptomic analysis, we report that polo-like kinase 1 (PLK1) is an important hub gene defining patient prognosis in pancreatic cancer and that RNA methylation is involved in regulating its cell cycle-specific expression. We found that insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2) binds to m6A of PLK1 3′ untranslated region and is involved in upregulating PLK1 expression and that demethylation of this site activates the ataxia telangiectasia and Rad3-related protein pathway by replicating stress and increasing mitotic catastrophe, resulting in increased radiosensitivity. This suggests that PLK1 methylation is essential for cell cycle maintenance in pancreatic cancer and is a new therapeutic target.
first_indexed 2024-12-12T11:55:32Z
format Article
id doaj.art-7e0bd74eab3f4a91a581cff49c3255fe
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-12T11:55:32Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-7e0bd74eab3f4a91a581cff49c3255fe2022-12-22T00:25:12ZengNature PortfolioScientific Reports2045-23222022-06-0112112010.1038/s41598-022-15196-5N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinomaShotaro Tatekawa0Keisuke Tamari1Ryota Chijimatsu2Masamitsu Konno3Daisuke Motooka4Suguru Mitsufuji5Hirofumi Akita6Shogo Kobayashi7Yoshiki Murakumo8Yuichiro Doki9Hidetoshi Eguchi10Hideshi Ishii11Kazuhiko Ogawa12Department of Radiation Oncology, Osaka University Graduate School of MedicineDepartment of Radiation Oncology, Osaka University Graduate School of MedicineDepartment of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of MedicineDepartment of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of MedicineGenome Information Research Center, Research Institute for Microbial Diseases, Osaka UniversityDepartment of Gastroenterological Surgery, Osaka University Graduate School of MedicineDepartment of Gastroenterological Surgery, Osaka University Graduate School of MedicineDepartment of Gastroenterological Surgery, Osaka University Graduate School of MedicineDepartment of Pathology, Kitasato University School of MedicineDepartment of Gastroenterological Surgery, Osaka University Graduate School of MedicineDepartment of Gastroenterological Surgery, Osaka University Graduate School of MedicineDepartment of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of MedicineDepartment of Radiation Oncology, Osaka University Graduate School of MedicineAbstract In pancreatic cancer, methyltransferase-like 3 (METTL3), a N(6)-methyladenosine (m6A) methyltransferase, has a favorable effect on tumors and is a risk factor for patients’ prognosis. However, the details of what genes are regulated by METTL3 remain unknown. Several RNAs are methylated, and what genes are favored in pancreatic cancer remains unclear. By epitranscriptomic analysis, we report that polo-like kinase 1 (PLK1) is an important hub gene defining patient prognosis in pancreatic cancer and that RNA methylation is involved in regulating its cell cycle-specific expression. We found that insulin like growth factor 2 mRNA binding protein 2 (IGF2BP2) binds to m6A of PLK1 3′ untranslated region and is involved in upregulating PLK1 expression and that demethylation of this site activates the ataxia telangiectasia and Rad3-related protein pathway by replicating stress and increasing mitotic catastrophe, resulting in increased radiosensitivity. This suggests that PLK1 methylation is essential for cell cycle maintenance in pancreatic cancer and is a new therapeutic target.https://doi.org/10.1038/s41598-022-15196-5
spellingShingle Shotaro Tatekawa
Keisuke Tamari
Ryota Chijimatsu
Masamitsu Konno
Daisuke Motooka
Suguru Mitsufuji
Hirofumi Akita
Shogo Kobayashi
Yoshiki Murakumo
Yuichiro Doki
Hidetoshi Eguchi
Hideshi Ishii
Kazuhiko Ogawa
N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
Scientific Reports
title N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
title_full N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
title_fullStr N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
title_full_unstemmed N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
title_short N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
title_sort n 6 methyladenosine methylation regulated polo like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma
url https://doi.org/10.1038/s41598-022-15196-5
work_keys_str_mv AT shotarotatekawa n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT keisuketamari n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT ryotachijimatsu n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT masamitsukonno n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT daisukemotooka n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT sugurumitsufuji n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT hirofumiakita n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT shogokobayashi n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT yoshikimurakumo n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT yuichirodoki n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT hidetoshieguchi n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT hideshiishii n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma
AT kazuhikoogawa n6methyladenosinemethylationregulatedpololikekinase1cellcyclehomeostasisasapotentialtargetofradiotherapyinpancreaticadenocarcinoma